THE PRESENT INVENTION PROVIDES SUBSTITUTED 8-[6-AMINO-3-PYRIDYL]XANTHINES LIKE THE COMPOUND SHOWN IN THE FOLLOWING FORMULA: AND PHARMACEUTICAL COMPOSITIONS THAT ARE SELECTIVE ANTAGONISTS OF A2B ADENOSINE RECEPTORS (ARs). THESE COMPOUNDS AND COMPOSITIONS ARE USEFUL AS PHARMACEUTICAL AGENTS.